#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Systemic sclerosis pulmonary Ewing's sarcoma metastatic Acute myeloid leukaemia (in remission) Hypochromic anaemia Thalassaemia Endocrine ophthalmopathy Neuronal ceroid lipofuscinosis Keratosis follicular Ataxia telangiectasia Medullary thyroid cancer Graft versus host disease Epilepsy Raynaud's phenomenon Hepatitis B Metastatic malignant melanoma More trials…

    Learn about Rare Diseases

    Retinoblastoma – Life with Disease CADASIL – Diagnostics Atypical teratoid/rhabdoid tumour of CNS – Basic Information VEXAS syndrome – Basic Information Hepatoblastoma – Trials in Disease Leiomyosarcoma recurrent – Diagnostics Methylmalonic acidaemia – Diagnostics Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Life with Disease Soft tissue sarcoma Haemophagocytic lymphohistiocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tinlarebant Tyrosine Ecoo4 Raludotatug Deruxtecan Pal1-15 Acetate Mk-1084 Vinflunine Cart 19/22 T Cells Teriflunomide Fludarabine Phosphate Ph. Eur. Triheptanoin Anhydrous Cidofovir Cefixime Trihydrate GSKVX000000017986 Cd7-Cart01 Epcoritamab Leucine Gd2Il18Cart RNK001 Nesolicaftor More therapies…

    Learn about Your Condition

    Immune system disorder Neuropathic arthropathy Endometrial cancer recurrent Subdural haematoma Muscle spasticity Anogenital warts Leukoencephalopathy Lung adenocarcinoma Breast conserving surgery Dermatitis Myeloproliferative neoplasm Drug use disorder Amyloidosis Colour blindness Lymphocytic lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Dexamethasone Phosphate for Reducing Breathing Problems in Children with Upper Airway Obstruction in Intensive Care

    Recruiting

    3 1 1
    Investigated Drugs:
    • Dexamethasone Phosphate
    France

  • Study on Blinatumomab, Ponatinib, and Isatuximab for Adults Aged 18-65 with Newly Diagnosed Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Lymphocytic leukaemia
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Ponatinib
    • Blinatumomab
    • Isatuximab
    Belgium France

  • Study on Docetaxel, Cabazitaxel, and Darolutamide for Men with Metastatic Castration-Resistant Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Cabazitaxel
    • Darolutamide
    • Docetaxel
    The Netherlands

  • Study on the Use of OTL-103 Gene Therapy and Drug Combination for Patients with Wiskott-Aldrich Syndrome

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Immunodeficiency
    Investigated Drugs:
    • Etuvetidigene Autotemcel
    • Lenograstim
    • Plerixafor
    Italy

  • Study of RBD5044 in Adults with Mixed Dyslipidemia to Evaluate its Safety and Effectiveness

    Recruiting

    2 1 1
    Investigated Drugs:
    • Rbd5044 Sodium
    Poland Sweden

  • A Study of OSU6162 in Adults with Bipolar Depression to Evaluate Safety and Effectiveness

    Recruiting

    2 1 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • 3-(3-Methanesulfonyl-Phenyl)-1-Propyl-Piperidine Hydrochloride
    Sweden
Previous Page
1 … 629 630 631 632 633 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!